Journal of Viral Hepatitis

Cover image for Vol. 19 Issue 10

October 2012

Volume 19, Issue 10

Pages 677–756

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    1. Didanosine (ddI) associates with increased liver fibrosis in adult HIV–HCV coinfected patients (pages 685–693)

      T. Suárez-Zarracina, E. Valle-Garay, J. Collazos, A. H. Montes, V. Cárcaba, J. A. Carton and V. Asensi

      Article first published online: 15 MAR 2012 | DOI: 10.1111/j.1365-2893.2012.01596.x

    2. Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C (pages 694–703)

      F. Matsuda, Y. Torii, H. Enomoto, C. Kuga, N. Aizawa, Y. Iwata, M. Saito, H. Imanishi, S. Shimomura, H. Nakamura, H. Tanaka, H. Iijima, H. Tsutsui, Y. Tanaka and S. Nishiguchi

      Article first published online: 29 MAY 2012 | DOI: 10.1111/j.1365-2893.2012.01598.x

    3. SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study (pages 704–710)

      E. Fransvea, P. Trerotoli, R. Sacco, V. Bernabucci, M. Milella, N. Napoli, A. Mazzocca, E. Renna, M. Quaranta, G. Angarano, E. Villa, S. Antonaci and G. Giannelli

      Article first published online: 30 MAR 2012 | DOI: 10.1111/j.1365-2893.2012.01604.x

    4. Interobserver discrepancy in liver fibrosis using transient elastography (pages 711–715)

      B. Roca, E. Resino, V. Torres, E. Herrero and M. Penades

      Article first published online: 27 MAR 2012 | DOI: 10.1111/j.1365-2893.2012.01608.x

    5. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro (pages 716–723)

      C. M. Martin, J. A. Welge, S. D. Rouster, M. T. Shata, K. E. Sherman and J. T. Blackard

      Article first published online: 4 JUN 2012 | DOI: 10.1111/j.1365-2893.2012.01595.x

    6. Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels (pages 724–731)

      J. W. Shin, S. W. Jung, B. R. Park, C. J. Kim, J. B. Eum, B. G. Kim, I. D. Jeong, S.-J. Bang, S.-H. Lee, S. R. Kim and N. H. Park

      Article first published online: 15 MAR 2012 | DOI: 10.1111/j.1365-2893.2012.01599.x

    7. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis (pages 732–743)

      H. L.Y. Chan, Y. C. Chen, E. J. Gane, S. K. Sarin, D. J. Suh, T. Piratvisuth, B. Prabhakar, S. G. Hwang, G. Choudhuri, R. Safadi, T. Tanwandee, A. Chutaputti, C. Yurdaydin, W. Bao, C. Avila and A. Trylesinski

      Article first published online: 15 MAR 2012 | DOI: 10.1111/j.1365-2893.2012.01600.x

    8. Large hepatitis delta antigen activates STAT-3 and NF-κB via oxidative stress (pages 744–753)

      V. Williams, S. Brichler, E. Khan, M. Chami, P. Dény, D. Kremsdorf and E. Gordien

      Article first published online: 22 APR 2012 | DOI: 10.1111/j.1365-2893.2012.01597.x

SEARCH

SEARCH BY CITATION